A visual cortical prosthesis (VCP) has long been proposed as a strategy for restoring useful vision to the blind, under the assumption that visual percepts of small spots of light produced with electrical stimulation of visual cortex (phosphenes) will combine into coherent percepts of visual forms, like pixels on a video screen. We tested an alternative strategy in which shapes were traced on the surface of visual cortex by stimulating electrodes in dynamic sequence. In both sighted and blind participants, dynamic stimulation enabled accurate recognition of letter shapes predicted by the brain’s spatial map of the visual world. Forms were presented and recognized rapidly by blind participants, up to 86 forms per minute. These findings demonstrate that a brain prosthetic can produce coherent percepts of visual forms.
Category: biotech/medical – Page 1,832
Israeli entrepreneurs and researchers have introduced facemask and face shield inventions we want to tell you about.
Let’s begin with an update on that first article highlighting washable masks from Sonovia and from Argaman. Each uses its own proprietary technology to embed microbe-killing metallic particles into textiles.
Now that we’re all covering our faces to avoid COVID-19, Israeli innovators are stepping up invention of antiviral masks, shields and stickers.
Schizophrenia is a devastating psychiatric disorder characterized by positive, negative and cognitive symptoms. While aberrant dopamine system function is typically associated with the positive symptoms of the disease, it is thought that this is secondary to pathology in afferent regions. Indeed, schizophrenia patients show dysregulated activity in the hippocampus and prefrontal cortex, two regions known to regulate dopamine neuron activity. These deficits in hippocampal and prefrontal cortical function are thought to result, in part, from reductions in inhibitory interneuron function in these brain regions. Therefore, it has been hypothesized that restoring interneuron function in the hippocampus and/or prefrontal cortex may be an effective treatment strategy for schizophrenia. In this article, we will discuss the evidence for interneuron pathology in schizophrenia and review recent advances in our understanding of interneuron development. Finally, we will explore how these advances have allowed us to test the therapeutic value of interneuron transplants in multiple preclinical models of schizophrenia.
Schizophrenia is devastating psychiatric disorder that affects approximately 1% of the population1. Positive symptoms, such as paranoia, grandiosity, delusions, and hallucinations, are often the most striking features of the disorder; however, schizophrenia patients also display characteristic negative and cognitive symptoms, which can be severely debilitating. Negative symptoms, such as blunted affect, emotional withdrawal, and social avoidance and cognitive symptoms, including disruptions in working memory, attentional deficits, disorganized thought, and cognitive inflexibility, can negatively influence social and occupational functioning and diminish quality of life2–4. Currently prescribed antipsychotic medications, which act as antagonists at the dopamine D2 receptor5, have been somewhat effective in treating the positive symptoms of schizophrenia6.
Circa 2019 face_with_colon_three
Multipotent cells are critical to regenerative medicine and its associated deployment strategies. Localizing an abundant source of autologous, adult stem cells circumvents the immunological prohibitions of allogeneity and ethical dilemmas of embryologic stem cells, respectively. Classically, these cells have been described as mesenchymal stem cells (MSCs). In this chapter, we characterize adipose tissue as a unique source of MSCs because of its ubiquity, redundancy, and procurability. Specifically, lipoaspirates can be minimally processed to provide a heterogenous, cell-dense isolate – the stromal vascular fraction (SVF) – composed of terminally differentiated vessel-associated cell lines as well as putative progenitor cells. These cells have been cultured and expanded, giving rise to a dynamic cell line termed adipose-derived stromal cells (ASCs). SVF and ASC cell isolates are often administered by standard clinical routes including parenteral, topical application, and local injection in the clinical translational studies of cardiovascular ischemia, neurological injury, rheumatologic and orthopedic disease as well as advanced wound care and tissue engineering. These clinical applications raise safety concerns specific to administration, sequestration, and tumor growth augmentation. Further studies SVF and ASC cells are necessary to realize their potential in a regenerative medicine capacity.
Wildlife officials hoped it was not capable of killing native species in the United States, but it’s causing die-offs throughout the southwest.
The interplay between the commensal microbiota and the mammalian immune system development and function includes multifold interactions in homeostasis and disease. The microbiome plays critical roles in the training and development of major components of the host’s innate and adaptive immune system, while the immune system orchestrates the maintenance of key features of host-microbe symbiosis. In a genetically susceptible host, imbalances in microbiota-immunity interactions under defined environmental contexts are believed to contribute to the pathogenesis of a multitude of immune-mediated disorders. Here, we review features of microbiome-immunity crosstalk and their roles in health and disease, while providing examples of molecular mechanisms orchestrating these interactions in the intestine and extra-intestinal organs. We highlight aspects of the current knowledge, challenges and limitations in achieving causal understanding of host immune-microbiome interactions, as well as their impact on immune-mediated diseases, and discuss how these insights may translate towards future development of microbiome-targeted therapeutic interventions.
Simulators that can rapidly test trillions of options would accelerate the slow and costly process of human clinical trials.
I always enjoy the perspective of David Wood, and in this session of the London Futurists there is a panel discussion about genetic engineering in the future.
Our DNA is becoming as readable, writable, and hackable as our information technology. The resulting genetic revolution is poised to transform our healthcare, our choices for the characteristics of the next generation, and our evolution as a species. The future could bring breathtaking advances in human well-being, but it could also descend into a dangerous genetic arms race.
These claims are made in the recent book “Hacking Darwin: Genetic Engineering and the Future of Humanity”, https://hackingdarwin.com/ by Technology Futurist Jamie Metzl, https://jamiemetzl.com/
Jamie’s view is that society isn’t at all ready for the fast-approaching future of widespread genetic hacking.
Here is some feedback for his book:
Maryland reported its highest number of new COVID-19 cases on Tuesday—just four days after the state began easing public health restrictions aimed at thwarting the spread of disease.
Though state officials note that an increase in testing and a backlog of test results may partly explain the spike, the case counts overall suggest that disease transmission has not declined in the lead-up to re-opening—and transmission could very easily increase as residents begin venturing into public spaces more frequently.
Maryland’s outcome may hold lessons for other states attempting their own reopening. As of today, May 20, all 50 states have begun easing restrictions at some level, according to The Washington Post.
Before there were animals, bacteria or even DNA on Earth, self-replicating molecules were slowly evolving their way from simple matter to life beneath a constant shower of energetic particles from space.
In a new paper, a Stanford professor and a former post-doctoral scholar speculate that this interaction between ancient proto-organisms and cosmic rays may be responsible for a crucial structural preference, called chirality, in biological molecules. If their idea is correct, it suggests that all life throughout the universe could share the same chiral preference.
Chirality, also known as handedness, is the existence of mirror-image versions of molecules. Like the left and right hand, two chiral forms of a single molecule reflect each other in shape but don’t line up if stacked. In every major biomolecule—amino acids, DNA, RNA—life only uses one form of molecular handedness. If the mirror version of a molecule is substituted for the regular version within a biological system, the system will often malfunction or stop functioning entirely. In the case of DNA, a single wrong handed sugar would disrupt the stable helical structure of the molecule.